Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126137163 | 12613716 | 3 | F | 20160511 | 20160916 | 20160802 | 20160926 | EXP | JP-NOVOPROD-502610 | NOVO NORDISK | 70.00 | YR | E | M | Y | 48.00000 | KG | 20160926 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126137163 | 12613716 | 1 | PS | VICTOZA | LIRAGLUTIDE | 1 | Subcutaneous | 0.3 MG, QD | Y | UNKNOWN | 22341 | .3 | MG | SOLUTION FOR INJECTION | QD | ||||
| 126137163 | 12613716 | 2 | C | RYZODEG 70/30 | INSULIN ASPARTINSULIN DEGLUDEC | 1 | Subcutaneous | 8 U, QD | UNKNOWN | 0 | 8 | DF | SOLUTION FOR INJECTION | QD | |||||
| 126137163 | 12613716 | 3 | C | RYZODEG 70/30 | INSULIN ASPARTINSULIN DEGLUDEC | 1 | Subcutaneous | 12 U, QD | UNKNOWN | 0 | 12 | DF | SOLUTION FOR INJECTION | QD | |||||
| 126137163 | 12613716 | 4 | C | RYZODEG 70/30 | INSULIN ASPARTINSULIN DEGLUDEC | 1 | Subcutaneous | 14 U, QD | UNKNOWN | 0 | 14 | DF | SOLUTION FOR INJECTION | QD | |||||
| 126137163 | 12613716 | 5 | C | RYZODEG 70/30 | INSULIN ASPARTINSULIN DEGLUDEC | 1 | Unknown | 12 U, QD | UNKNOWN | 0 | 12 | DF | SOLUTION FOR INJECTION | QD | |||||
| 126137163 | 12613716 | 6 | C | AMARYL | GLIMEPIRIDE | 1 | Unknown | 2 MG, QD | UNKNOWN | 0 | 2 | MG | QD | ||||||
| 126137163 | 12613716 | 7 | C | TRAZENTA | LINAGLIPTIN | 1 | Unknown | 5 MG, QD | UNKNOWN | 0 | 5 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126137163 | 12613716 | 1 | Type 2 diabetes mellitus |
| 126137163 | 12613716 | 2 | Type 2 diabetes mellitus |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126137163 | 12613716 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126137163 | 12613716 | Abdominal discomfort | |
| 126137163 | 12613716 | Decreased appetite | |
| 126137163 | 12613716 | Malaise | |
| 126137163 | 12613716 | Retinal haemorrhage |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126137163 | 12613716 | 1 | 20160510 | 0 | ||
| 126137163 | 12613716 | 2 | 20160314 | 0 | ||
| 126137163 | 12613716 | 3 | 20160328 | 0 | ||
| 126137163 | 12613716 | 4 | 20160426 | 0 | ||
| 126137163 | 12613716 | 5 | 20160510 | 0 | ||
| 126137163 | 12613716 | 6 | 20160328 | 0 | ||
| 126137163 | 12613716 | 7 | 20160426 | 0 |